Therefore, the current study aimed to examine the influence of different administration routes and gene polymorphisms of CYP2C19, CYP3A4 and ABCB1 on the serum VRC concentration among Chinese patients with hematologic malignancies. This evidence concerns the gene CYP2C19 and hematologic disorder.